Earn CME: https://naccme.com/program/19-gdugi-5 In this webcast from the ‘Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing’ symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Pashtoon Kasi discusses best practices for the management of adverse events associated with the treatment of HCC. © 2019 Imedex, an HMP Company
HCC: Management of Adverse Events with New Therapeutic Approaches
